Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia

NCT04578210 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
84
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Instituto de Investigación Hospital Universitario La Paz

Collaborators